Dressings Segment to Lead Middle East and North Africa Advanced Wound Care Market Based on Product Type During 2025–2031
According to our new research study on “Middle East and North Africa Advanced Wound Care Market Forecast to 2031 – Regional Analysis – by Product Type, Wound Type, and End User,” the Middle East and North Africa advanced wound care market size is expected to grow from US$ 197.65 million in 2024 to US$ 270.25 million by 2031; the market is expected to register a CAGR of 4.7% during 2025–2031. Major factors driving the Middle East and North Africa advanced wound care market growth include the increasing prevalence of chronic diseases, aging population, improvements in healthcare infrastructure, and public health investment.
Advanced wound care is a set of medical treatments and products that facilitate the healing process of chronic, complicated, or resistant wounds to healing, e.g., diabetic foot ulcers, pressure injuries, and venous leg ulcers, which have not responded to standard dressings or basic care. Smart and connected wound dressings are expected to emerge as a major Middle East and North Africa advanced wound care market trend in the coming years.
Middle East and North Africa Advanced Wound Care Market, by region, 2024 (%)
Middle East and North Africa Advanced Wound Care Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Dressings, Devices, and Biological Skin Substitutes), Wound Type (Chronic Wounds and Acute Wounds), End User (Hospitals, Specialty Clinics, Homecare Settings, and Others), and Region
Middle East and North Africa Advanced Wound Care Market 2031
Download Free Sample
Source: The Insight Partners Analysis
Middle East and North Africa Advanced Wound Care Market Analysis Based on Segmental Evaluation:
Based on product type, the Middle East and North Africa advanced wound care market is segmented into dressings, devices, and biological skin substitutes. In 2024, the dressings segment held a significant Middle East and North Africa advanced wound care market share. Advanced wound dressings are used to treat chronic wounds, including diabetic foot ulcers, which are the major cause of morbidity in the Middle East and North Africa. This region records the highest global prevalence of diabetes, which is 17.6% among adults aged 20-79; thus, more than 73 million people are affected, as per the International Diabetes Federation's data for 2025. The rate of diabetic foot ulcer ranges from 5 to 20% in the MENA region, while Saudi Arabia has an average of 11.85%, Egypt - 4.2%, Jordan - 4.65%, and Bahrain - 5.9%. These dressings, e.g., hydrocolloid, foam, and antimicrobial varieties such as silver-impregnated or honey-based ones, provide moisture balance, control infection, and allow autolytic debridement, thus facilitating the reduction of healing time and the risk of amputation in RLS, which are very common. A prospective Saudi Arabian study revealed that controlled-release ionic silver hydrophilic dressings led to faster wound closure than manuka honey-impregnated ones. Egyptian research on the combination of surgical debridement and manuka honey gauze resulted in infection clearance in 85% of cases, with granulation tissue formation accelerating; thus, a mere hospital ward can be the setting for a cost-efficient public hospital model to be readily adopted. Hypochlorous acid-based dressing, as an adjunct, is highly effective in resolving diabetic foot infections with a 40% healing rate, as confirmed by trials reviewed by WHO. Dressings are the primary means of care. They facilitate outpatient management and are less demanding of the healthcare system in the countries with a high prevalence of diabetes, such as the UAE and Qatar.
The scope of the Middle East and North Africa advanced wound care market report includes an assessment of the market performance in the Middle East and North Africa. In terms of revenue, Saudi Arabia dominated the Middle East and North Africa advanced wound care market share in 2024.
The Middle East and North Africa advanced wound care market is segmented into the UAE, Saudi Arabia, Egypt, Iraq, Algeria, Jordan, and the Rest of MENA. The surge in diabetic foot ulcers and pressure ulcers as a result of the increasing prevalence of diabetes and obesity has escalated the demand for wound care solutions. In addition, the elderly population is turning advanced wound management into a necessity.
Rising healthcare infrastructure, awareness of modern wound care technologies, and government healthcare expenditure are among the key factors propelling the market growth. There is a transition in the region from conventional methods of wound care to technologically advanced products such as hydrocolloids, foam dressings, and negative pressure wound therapy. The growth of private healthcare providers and the rise in medical tourism, especially in the Gulf Cooperation Council (GCC) countries, enhances the demand for advanced wound care management solutions.
Smith & Nephew Plc, Convatec Group Plc, Coloplast AS, Integra LifeSciences Holdings Corp, Paul Hartmann AG, Molnlycke Health Care AB, MiMedx Group Inc, Cardinal Health Inc, Solventum Corporation, B Braun SE, Medline Industries LP, Elkem ASA are among the leading companies profiled in the Middle East and North Africa advanced wound care market report.
Based on product type, the Middle East and North Africa advanced wound care market is segmented into dressings, devices, and biological skin substitutes. Per wound type, the market is bifurcated into chronic wounds and acute wounds. By end user, the market is segmented into hospitals, specialty clinics, homecare settings, and others. Geographically, the market is categorized into the Middle East and North Africa (UAE, Saudi Arabia, Egypt, Iraq, Algeria, Jordan, and the Rest of MENA).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com